Allergic reactions to the new mRNA-based COVID-19 vaccines are rare, typically mild and treatable, and they should not deter people from becoming vaccinated, according to a study led by researchers at the Stanford University School of Medicine. The findings were published online Sept. 17 in JAMA Network Open.
